Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological Malignancies
Ultra-deep next-generation sequencing has emerged in recent years as an important diagnostic tool for the detection and follow-up of tumor burden in most of the known hematopoietic malignancies. Meticulous and high-throughput methods for the lowest possible quantified disease are needed to address t...
Main Authors: | Ricardo Sánchez, Rosa Ayala, Joaquín Martínez-López |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/11/2832 |
Similar Items
-
Minimal residual disease detection and evolved IGH clones analysis in acute B lymphoblastic leukemia using IGH deep sequencing
by: Jinghua Wu, et al.
Published: (2016-10-01) -
Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
by: Qiumei Yao, et al.
Published: (2019-06-01) -
Validation and clinical application of a targeted next-generation sequencing gene panel for solid and hematologic malignancies
by: Iván Prieto-Potin, et al.
Published: (2020-10-01) -
Exploring next-generation sequencing in chronic lymphocytic leukemia
by: Ljungström, Viktor
Published: (2016) -
Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma
by: Alcoceba, M., et al.
Published: (2022)